Underlying NPAT is growing from $12.1m to $15.0m which is almost 25% growth. That growth is great.So the only question is has MNF done its homework on Pennytel? Let’s hope so.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025